|
21. The sales growth reflect strong performance of the Procrit, an anemia drug, Risperdal, an antipsychotic medication, and Duragesic, a transdermal patch for chronic pain. |
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
21. The sales growth reflect strong performance of the Procrit, an anemia drug, Risperdal, an antipsychotic medication, and Duragesic, a transdermal patch for chronic pain. |
|
|||||||||||||||||||||||||||||||||||||||||||||||